Sales rose 1.6% to $16.43 billion in the quarter ended July 29, beating analysts' estimates of $16.30 billion. Same-store sales rose 1.3%, also more than analysts had expected. Comparable digital sales surged 32%.
A recent Food and Drug Administration public meeting kicked off a two-month comment period during which stakeholders have been encouraged to share their input on how best to improve generic competition and what current barriers exist.
In his latest column, Drug Store News contributing editor Ed Rowland looks at the confluence of factors — from digital tools to consumer demands and the agility of competitors — complicating the OTC e-commerce business.